Skip to Main Content

Author Details

Jeremy P Kamil
Louisiana State University Health Sciences Center Shreveport
2000
60
25
PMIDPaper TitleJournal TitlePublished Year
36861992The Coming of Age of Nucleic Acid Vaccines during COVID-19.mSystems2023
37754763Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteins.J Virol2023
37287979SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines.Front Immunol2023
37377964Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines.Front Immunol2023
37467165A collaborative approach to improving representation in viral genomic surveillance.PLOS Glob Public Health2023
37131605Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteins.bioRxiv2023
36700653Virology under the Microscope-a Call for Rational Discourse.mSphere2023
36700642Virology under the Microscope-a Call for Rational Discourse.mBio2023
36700640Virology under the Microscope-a Call for Rational Discourse.J Virol2023
35076276Correction for Rando et al., "Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure".mSystems2022
35352979The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines.mBio2022
36129424COVID-19 drive-through mass vaccination in Northwest Louisiana.J La Public Health Assoc2022
36299431A collaborative approach to improve representation in viral genomic surveillance.bioRxiv2022
35946797The Akt Forkhead Box O Transcription Factor Axis Regulates Human Cytomegalovirus Replication.mBio2022
35258327Structural Dynamics and Molecular Evolution of the SARS-CoV-2 Spike Protein.mBio2022
34312390Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.Nat Commun2021
33851150Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.Res Sq2021
33594385Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677.medRxiv2021
33821288Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.medRxiv2021
33593976Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera.mBio2021
34508652Emergence of an early SARS-CoV-2 epidemic in the United States.Cell2021
34011552The Human Cytomegalovirus Protein UL116 Interacts with the Viral Endoplasmic-Reticulum-Resident Glycoprotein UL148 and Promotes the Incorporation of gH/gL Complexes into Virions.J Virol2021
34007076Virus variants: GISAID policies incentivize surveillance in global south.Nature2021
34007075UNESCO embraces open science to shape society's future.Nature2021
32694203FOXO transcription factors activate alternative major immediate early promoters to induce human cytomegalovirus reactivation.Proc Natl Acad Sci U S A2020
31801856Endoplasmic Reticulum (ER) Reorganization and Intracellular Retention of CD58 Are Functionally Independent Properties of the Human Cytomegalovirus ER-Resident Glycoprotein UL148.J Virol2020
33072616Control of Immediate Early Gene Expression for Human Cytomegalovirus Reactivation.Front Cell Infect Microbiol2020
32817961Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera.medRxiv2020
31409717Alternative promoters drive human cytomegalovirus reactivation from latency.Proc Natl Acad Sci U S A2019
31822584The Human Cytomegalovirus Nonstructural Glycoprotein UL148 Reorganizes the Endoplasmic Reticulum.mBio2019
29743375Expression Levels of Glycoprotein O (gO) Vary between Strains of Human Cytomegalovirus, Influencing the Assembly of gH/gL Complexes and Virion Infectivity.J Virol2018
29997207Human Cytomegalovirus Tropism Modulator UL148 Interacts with SEL1L, a Cellular Factor That Governs Endoplasmic Reticulum-Associated Degradation of the Viral Envelope Glycoprotein gO.J Virol2018
30045994The Human Cytomegalovirus Endoplasmic Reticulum-Resident Glycoprotein UL148 Activates the Unfolded Protein Response.J Virol2018
30544948Pathogen at the Gates: Human Cytomegalovirus Entry and Cell Tropism.Viruses2018
28681110Recent advances in CMV tropism, latency, and diagnosis during aging.Geroscience2017
26778574Preparation of the Human Cytomegalovirus Nuclear Egress Complex and Associated Proteins.Methods Enzymol2016
25348532Human cytomegalovirus resistance to deoxyribosylindole nucleosides maps to a transversion mutation in the terminase subunit-encoding gene UL89.Antimicrob Agents Chemother2015
26559829Viral Regulation of Cell Tropism in Human Cytomegalovirus.J Virol2015
25831500A viral regulator of glycoprotein complexes contributes to human cytomegalovirus cell tropism.Proc Natl Acad Sci U S A2015
25339763Human cytomegalovirus UL97 phosphorylates the viral nuclear egress complex.J Virol2015
24155370Human cytomegalovirus UL50 and UL53 recruit viral protein kinase UL97, not protein kinase C, for disruption of nuclear lamina and nuclear egress in infected cells.J Virol2014
24623439An epistatic relationship between the viral protein kinase UL97 and the UL133-UL138 latency locus during the human cytomegalovirus lytic cycle.J Virol2014
23536674The ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97.J Virol2013
23817384Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97.Antimicrob Agents Chemother2013
23427156Inactivation of retinoblastoma protein does not overcome the requirement for human cytomegalovirus UL97 in lamina disruption and nuclear egress.J Virol2013
22647701Marek's disease viral interleukin-8 promotes lymphoma formation through targeted recruitment of B cells and CD4+ CD25+ T cells.J Virol2012
21320689HATs on for drug resistance.Cell Host Microbe2011
21784501Sites and roles of phosphorylation of the human cytomegalovirus DNA polymerase subunit UL44.Virology2011
20547817Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir.Antimicrob Agents Chemother2010
20686030Inactivation and disassembly of the anaphase-promoting complex during human cytomegalovirus infection is associated with degradation of the APC5 and APC4 subunits and does not require UL97-mediated phosphorylation of Cdh1.J Virol2010
  • 1 - 50 of 60

Recommended Authors

Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 3
Stanford University School of Medicine
Career Start Year 2013
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 5
David Geffen School of Medicine, University of California los angeles
Career Start Year 2009
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 8
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 3
Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 0
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 2
David Geffen School of Medicine, University of California los angeles
Career Start Year 2006
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 2004
Number of shared co-authors 0
The Roslin Institute, The University of Edinburgh
Career Start Year 2003
Number of shared co-authors 3
Duke-NUS Medical School
Career Start Year 2003
Number of shared co-authors 0
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2003
Number of shared co-authors 4
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 5
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 7
MRC - University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 1998
Number of shared co-authors 0
Gilead Sciences Inc.
Career Start Year 1997
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 0
University of Cambridge
Career Start Year 1996
Number of shared co-authors 5
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 9
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 5
Cancer Research Institute, Central South University
Career Start Year 1995
Number of shared co-authors 1
Gladstone Institute of Virology
Career Start Year 1993
Number of shared co-authors 6
University of California Berkeley
Career Start Year 1993
Number of shared co-authors 2
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 7
University College London
Career Start Year 1992
Number of shared co-authors 4
University of California los angeles
Career Start Year 1992
Number of shared co-authors 7
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 5
Carver College of Medicine, University of Iowa
Career Start Year 1978
Number of shared co-authors 0

Collaborators

University of Arizona
Co-authored papers 11
Icahn School of Medicine at Mount Sinai
Co-authored papers 10
Louisiana State University
Co-authored papers 5
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 3
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Co-authored papers 3
University of Washington Medical Center
Co-authored papers 3
NYU Grossman School of Medicine
Co-authored papers 3
UC Berkeley
Co-authored papers 3
Fred Hutchinson Cancer Research Center
Co-authored papers 3
Columbia University
Co-authored papers 3
University of Iowa
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Fred Hutchinson Cancer Center
Co-authored papers 3
Oregon Health and Science University
Co-authored papers 3
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 3
University of Utah School of Medicine
Co-authored papers 3
University of Utah School of Medicine
Co-authored papers 3
Co-authored papers 3
University of Michigan ann arbor
Co-authored papers 3
Duke University School of Medicine
Co-authored papers 3
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 3
Co-authored papers 3
Rockefeller University
Co-authored papers 3
The Children's Hospital of Philadelphia
Co-authored papers 3
University of North Carolina at Chapel Hill.
Co-authored papers 3
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Co-authored papers 3